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Jocelyn L. Tan-Shalaby1,2*, Jennifer Carrick1, Krystal Edinger1,2, Dana Genovese1,2, Andrew D. Liman1,2,
Vida A. Passero1,2 and Rashmikant B. Shah1Erratum
After publication of the original article [1], the author
found that a word had been incorrectly used in the article
body in the paragraph entitled ‘Effect on the tumor’ in the
‘Results’ section:
“The fourth patient, patient 17, an 84 year old with
chemo-naive stage IV squamous cell lung carcinoma
dieted until 16 weeks and finished the trial with stable
disease while achieving excellent ketosis (+2).”
The word “squamous” should be “adenocarcinoma”.
Therefore the correct sentence should read “The fourth
patient, patient 17, an 84 year old with chemo-naive
stage IV adenocarcinoma cell lung carcinoma dieted
until 16 weeks and finished the trial with stable disease
while achieving excellent ketosis (+2).”
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